'Breathtaking progress,' against cancer but challenges remain

June 1, 2014 by Jean-Louis Santini

Cancer researchers say major progress is being made against a malady that kills more than seven million people worldwide each year, but funding is short and many challenges remain.

Convincing people to eat healthy, exercise and quit smoking could drastically cut back on many preventable cancers, and a host of environmental factors that may lead to have yet to be solved by science, experts say.

Still, researchers gathered at the American Society of Clinical Oncology annual conference here said there is plenty of cause for optimism.

This year's event, ASCO's 50th, brings together 30,000 doctors, researchers and pharmaceutical agents from around the world.

"Scientifically the field of oncology has never been more exciting," said Clifford Hudis, president of ASCO.

He cited new targeted therapies that take aim at the cellular functions of tumors, leading to progress against some difficult to treat cancers. Also, immunotherapy is an exciting field that uses a patient's own immune system to attack tumors, and is showing promise against melanoma, leukemia, and a handful of other cancers.

"We have made incredible progress in 50 years," said Jyoti Patel, a cancer specialist at Northwestern University.

"What has been very exciting in the past several decades is the understanding of the biology of cancer, an effort of working together to catalogue the make-up and the molecular aberrations that distinguish cancer," Patel told AFP.

"In 2014 there will be almost 14 million cancer survivors in the US, and that number is expected to grow twofold over the next decades."

The death rate from cancer has dropped about 1.5 percent annually over the past decade, and a person diagnosed with cancer today has a higher than 66 percent chance of being alive in five years, according to US government statistics.

"The scientific breakthroughs in cancer are occurring at a breathtaking pace and are being translating into new drugs and devices that benefit patients more quickly than ever before," said Richard Schilsky, chief medical officer of ASCO.

However, he warned that this progress is in jeopardy due to a shortage of research funds, particularly from the National Institutes of Health, the largest government funder of US scientific research wich in 2013 had a budget of 28.9 billion dollars.

"The NIH budget has been flat for more than a decade and when adjusted for inflation... is nearly 25 percent lower today than in 2003," he said.

Hudis agreed that more government funding is needed.

"The nation's continued investment is critical if we are to make further progress against cancer and accelerated the progress already under way," said Hudis.

Risk factors

He also called for more focus on addressing both environmental and that drive up the cancer burden in the United States and around the world.

"While tobacco has long been the leading risk factor for cancer, obesity is a growing problem not only for the US but worldwide," he said.

"Obesity is overtaking tobacco, at least in the US, as the leading modifiable risk factor for multiple cancers," he said, mentioning colon and prostate cancer among the diseases susceptible to weight and eating habits.

A recent study in The Lancet found that one third of the world was overweight or obese.

"About two-thirds of cancers could be avoided if we changed our lifestyle, our diet and our sun exposure," said Patel.

She also urged more widespread vaccination against human papillomavirus (HPV) which can cause cancers of the cervix, anus, penis, head, neck and throat—as well as improved vaccination against hepatitis which can lead to liver cancer.

Smoking also remains a top cause of cancer.

"So we need better education and stricter regulations for the tobacco industry," Patel said.

Explore further: Game-changing shift occurring in cancer discovery and treatment

Related Stories

Game-changing shift occurring in cancer discovery and treatment

December 11, 2013
Research advances that have come to fruition over the past year demonstrate extraordinary progress in the fight against cancer, according to a new report released today by the American Society of Clinical Oncology (ASCO). ...

Pancreatic cancer projected to become second leading cause of cancer-related death in the US by 2030

May 20, 2014
(Medical Xpress)—An analysis projects pancreatic and liver cancers to become second and third leading causes of cancer-related death in the United States by 2030, respectively, behind lung cancer, which will remain the ...

Report sees continued advances in war against cancer

September 17, 2013
(HealthDay)—Nearly 14 million people in the United States, or one in 23, are now cancer survivors.

Radiation for prostate cancer linked to secondary cancers, study finds

May 30, 2014
Among men treated for prostate cancer, those who received radiation therapy were more likely to develop bladder or rectal cancer, according to a new study from the University of Michigan Comprehensive Cancer Center.

ASCO report highlights progress against cancer in last year

December 14, 2013
(HealthDay)—Progress against cancer is described in the ninth annual report of the American Society of Clinical Oncology, published online Dec. 10 in the Journal of Clinical Oncology.

Lung cancer not on many women's radar, survey finds

May 13, 2014
(HealthDay)—U.S. women still see breast cancer as a bigger killer than lung cancer, despite the fact that lung cancer kills more Americans each year—women and men—than any other cancer.

Recommended for you

New approach attacks 'undruggable' cancers from the outside in

January 23, 2018
Cancer researchers have made great strides in developing targeted therapies that treat the specific genetic mutations underlying a patient's cancer. However, many of the most common cancer-causing genes are so central to ...

Study: Cells of three advanced cancers die with drug-like compounds that reverse chemo failure

January 23, 2018
Researchers at Southern Methodist University have discovered three drug-like compounds that successfully reverse chemotherapy failure in three of the most commonly aggressive cancers—ovarian, prostate and breast.

'Hijacker' drives cancer in some patients with high-risk neuroblastoma

January 23, 2018
Researchers have identified mechanisms that drive about 10 percent of high-risk neuroblastoma cases and have used a new approach to show how the cancer genome "hijacks" DNA that regulates other genes. The resulting insights ...

Enzyme inhibitor combined with chemotherapy delays glioblastoma growth

January 23, 2018
In animal experiments, a human-derived glioblastoma significantly regressed when treated with the combination of an experimental enzyme inhibitor and the standard glioblastoma chemotherapy drug, temozolomide.

Researchers identify a protein that keeps metastatic breast cancer cells dormant

January 23, 2018
A study headed by ICREA researcher Roger Gomis at the Institute for Research in Biomedicine (IRB Barcelona) has identified the genes involved in the latent asymptomatic state of breast cancer metastases. The work sheds light ...

Boosting cancer therapy with cross-dressed immune cells

January 22, 2018
Researchers at EPFL have created artificial molecules that can help the immune system to recognize and attack cancer tumors. The study is published in Nature Methods.


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.